WebMar 15, 2024 · Coherus BioSciences Inc. (NASDAQ:CHRS)’s beta value is holding at 0.95, while the average true range (ATR) indicator is currently reading 0.52. Considering analysts have assigned the stock a price target range of $9.00-$30.00 as the low and high respectively, we find the trailing 12-month average consensus price target to be $17.43. WebChris entered the insurance industry in 1987. His area of expertise encompasses group insurance and employee benefits for companies …
Christian Clark, CIP, CHRS, RFC, LUTCF - Owner - LinkedIn
WebMar 31, 2024 · Mar 7. Coherus BioSciences, Inc. (CHRS) Q4 2024 Earnings Call Transcript. Mar 6. Coherus BioSciences (CHRS) Reports Q4 Loss, Misses Revenue Estimates. Mar 6. Coherus BioSciences Non-GAAP EPS of -$0.60 beats by $0.09, revenue of $45.4M misses by $2.57M. Mar 6. Coherus BioSciences Reports Fourth Quarter and Full Year 2024 … WebCHRS Coherus BioSciences Inc. Stock Price & News - WSJ Coherus BioSciences Inc. CHRS (U.S.: Nasdaq) AT CLOSE 4:00 PM EDT 04/06/23 $7.66USD -0.02 -0.26% … chinn limited
Coherus BioSciences (CHRS) Stock Forecast, Price & News
WebFeb 17, 2024 · Coherus Biosciences Inc (CHRS) stock has risen 3.82% while the S&P 500 is down -0.71% as of 12:22 PM on Friday, Feb 17. CHRS has gained $0.28 from the previous closing price of $7.46 on volume of 233,610 shares. Over the past year the S&P 500 has fallen -7.28% while CHRS is down -39.69%. CHRS lost -$3.60 per share the … WebWe are dedicated to improving the availability of high-value, high-quality therapeutics. Our pipeline and product portfolio spans multiple therapeutic areas including oncology, immunology, and ophthalmology. We market … WebWriting, no viable Mac OS X malware has emerged. You see it in soldiers, pilots, loggers, athletes, cops, roofers, and hunters. People are always trying to trick and rob you by … chinn library events